Novo Nordisk cuts Wegovy price as CEO pledges to go 'all in' on weight loss pill
17.11.2025
COPENHAGEN (Reuters) -Novo Nordisk said on Monday it would lower the U. price of its injectable Wegovy obesity drug and pledged to go "all in" on its upcoming oral weight-loss pill, as the firm races to claw back lost ground in the lucrative market.